ICON
Runs outsourced clinical development programs for drug and medical-device makers worldwide.
$170.02
After-hours close+0.12 (+0.07%)
At close$169.90(+0.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $2.69 | — | — |
| Jul 2026 | $2.55 | $2.56 | +0.4% |
| Jun 2026 | $2.43 | $1.37 | −43.6% |
| Jun 2026 | $2.47 | — | — |
| Jun 2026 | $2.47 | $2.52 | +2.0% |
| Jun 2026 | $3.20 | $2.52 | −21.3% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||
| May 2026 | |||
| Oct 2025 | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | $2.69 | — | — | $2.01B | — | — |
| Jul 29, 2026 | $2.55 | $2.56 | +0.4% | $2.00B | $2.06B | +3.0% |
| Jun 23, 2026 | $2.43 | $1.37 | −43.6% | $2.00B | $2.03B | +1.8% |
| Jun 17, 2026 | $2.47 | — | — | $1.99B | — | — |
| Jun 10, 2026 | $2.47 | $2.52 | +2.0% | $1.99B | $2.11B | +6.1% |
| Jun 3, 2026 | $3.20 | $2.52 | −21.3% | $1.99B | $2.11B | +6.1% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | ||||||
| May 27, 2026 | ||||||
| Oct 22, 2025 | ||||||
| Jul 23, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Feb 19, 2025 | ||||||
| Oct 23, 2024 | ||||||
| Jul 24, 2024 | ||||||
| Apr 24, 2024 | ||||||
| Feb 21, 2024 | ||||||
| Oct 25, 2023 | ||||||
| Jul 26, 2023 | ||||||
| Apr 26, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Jul 27, 2022 | ||||||
| Apr 27, 2022 | ||||||
| Feb 22, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Jul 21, 2021 | ||||||
| Apr 28, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Oct 21, 2020 | ||||||
| Jul 22, 2020 | ||||||
| Apr 22, 2020 | ||||||
| Feb 19, 2020 | ||||||
| Oct 23, 2019 | ||||||
| Jul 24, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 20, 2019 | ||||||
| Oct 24, 2018 | ||||||
| Jul 25, 2018 | ||||||
| May 2, 2018 | ||||||
| Feb 15, 2018 | ||||||
| Oct 26, 2017 | ||||||
| Jul 27, 2017 | ||||||
| Apr 27, 2017 | ||||||
| Feb 16, 2017 | ||||||
| Oct 20, 2016 | ||||||
| Jul 26, 2016 | ||||||
| Apr 26, 2016 | ||||||